LTRN Lantern Pharma Inc
Company Analysis
Latest News
🔴 Lantern Pharma is trading 10.07% down today amid sharper biotech-sector losses
Lantern Pharma is trading at $1.25, down 10.07%, amid biotech-sector weakness. - No new company-specific announcement was identified for September 24, 2026. -...
🔴 Lantern Pharma is trading 5.8% down today amid biotech-sector weakness
Lantern Pharma is trading at $1.31, down 5.76%, as biotechnology stocks fall alongside higher Treasury yields, inflation concerns and weaker broader-market...
🔴 Lantern Pharma is trading 5% down in pre-market as immediate catalyst remains unclear
Lantern Pharma is trading 5.04% lower at $1.32 versus its September 23 close of $1.39; the immediate catalyst is unclear amid weaker U.S. index futures and...
🟢 Lantern Pharma is trading 7.91% up today in pre-market after USPTO allows LP-284 blood-cancer patent
Lantern Pharma is trading at $1.50, up 7.91%, after the USPTO issued a Notice of Allowance for its LP-284 blood-cancer treatment patent. - Allowed claims...
Lantern Pharma Wins a Patent Shield for Its Cancer Drug — But Can a $19 Million Company Afford to Use It?
Shares of Lantern Pharma surged 11.8% to $1.52 Tuesday after the U.S. Patent and Trademark Office gave the green light on a patent covering the company's...
🟢 Lantern Pharma is trading 11.76% up today after USPTO Notice of Allowance for LP-284 patent
Lantern Pharma is trading 11.76% higher at $1.52 after announcing a USPTO Notice of Allowance for an LP-284 treatment patent covering aggressive B-cell...
🟢 Lantern Pharma is trading 6% up today as biotech stocks rise
Lantern Pharma is trading 5.88% up at $1.44, primarily as broader positive biotech-sector sentiment lifts stocks. - The move follows three consecutive...
🟢 Lantern Pharma rises 6.6% — Biotech Sector Surges in Pre-Market on Multiple Positive News Snippets
With Biotech (XBI) up 2.6%, this looks like a sector-led move rather than a company-specific surprise. The biotechnology sector, as measured by the XBI ETF,...
🔴 Lantern Pharma is trading 5.67% down today as the specific reason remains unclear
Lantern Pharma is trading 5.67% down at $1.42, continuing the retreat from the September 21, 2026 close of $1.50, while the specific reason remains unclear. -...
🟢 Lantern Pharma is trading 9.66% up in pre-market with no identified company-specific catalyst
Lantern Pharma is trading 9.66% up at $1.64, with no new company-specific catalyst identified for September 22, 2026. - The latest notable announcement is a...
🟢 Lantern Pharma is trading 10.32% up in after-hours trading
Lantern Pharma is trading 10.32% up at $1.71 after-hours, with no clear company-specific catalyst identified. - Shares closed at $1.55 on September 18, 2026,...
🔴 Lantern Pharma is trading 5.26% down today — immediate cause unclear
Lantern Pharma is trading at $1.62 (-5.26%), with no clear company-specific negative catalyst identified for September 18, 2026. - The latest announcement is...
🔴 Lantern Pharma is trading 11% down today with no clear company-specific negative catalyst identified
Lantern Pharma is trading 11% down now at $1.72, with no clear company-specific negative catalyst identified. - The September 16, 2026, rally has reversed. -...
🔴 Lantern Pharma is trading 9.33% down today after September 16's advance; catalyst unclear
Lantern Pharma is trading at $1.75, down 9.33%, with no confirmed company-specific announcement explaining the September 17 decline. - The company announced a...
🟢 Lantern Pharma is trading 14.51% up today in pre-market with catalyst still unconfirmed
Lantern Pharma is trading 14.51% up at $2.21 in pre-market, with the catalyst unconfirmed. - The stock rose 13.53% to $1.93 on September 16. - No...
🟢 Lantern Pharma is trading 12.35% up today with no confirmed catalyst
Lantern Pharma is trading 12.35% up at $1.91 on September 16, 2026, despite broader biotech weakness; the move remains unexplained. - No company-specific...
🟢 Lantern Pharma is trading 7.7% up today; no catalyst confirmed
Lantern Pharma is trading 7.7% up at $1.83, after closing at $1.70 on September 15, 2026; the reason remains unconfirmed. - No company-specific announcement...
🔴 Lantern Pharma is trading 8% down today in pre-market; immediate catalyst remains unclear
Lantern Pharma is trading at $1.62, down 7.95%, while the immediate catalyst remains unclear. - No clear company-specific announcement was identified for...
🔴 Lantern Pharma is trading 5% down in pre-market amid broader risk-off conditions
Lantern Pharma is trading 5.08% down now at $1.68, with the decline appearing consistent with broader risk-off conditions. - No clear company-specific...
🟢 Lantern Pharma is trading 5.51% up today with no clear catalyst identified
Lantern Pharma is trading 5.51% up at $2.01, with no clear catalyst identified. - No September 8, 2026 company-specific announcement, filing, analyst action,...